Sales Performance - For the fiscal year 2023, the total sales amount of steam from Shengshi Thermal Power to Shengtai Pharmaceutical was RMB 146.5 million, which is below the revised annual cap of RMB 215.8 million[2] - The total sales amount of electricity from Shengshi Thermal Power to Shengtai Pharmaceutical for the fiscal year 2023 was RMB 60.3 million, lower than the revised annual cap of RMB 79.1 million[2] Revised Annual Caps - The revised annual caps for the new steam supply agreement for the two fiscal years ending December 31, 2024, are RMB 215.8 million and RMB 237.9 million respectively[2] - The revised annual caps for the new electricity supply agreement for the two fiscal years ending December 31, 2024, are RMB 79.1 million and RMB 87.2 million respectively[2] Supply Agreements - The new steam supply agreement is effective from January 1, 2022, to December 31, 2024, with an option to renew for up to three years[2] - The new electricity supply agreement is also effective from January 1, 2022, to December 31, 2024, with a similar renewal option[2] - The agreements aim to ensure that the steam and electricity produced primarily meet the production needs of the shareholders of Shengshi Thermal Power and Shengtai Pharmaceutical[2] Company Focus and Reporting - The company continues to focus on generating reasonable returns outside its core business through the supply of steam and electricity[2] - The board of directors has clarified certain errors in the annual report due to oversight, with revisions highlighted for reference[1] - The company maintains that all other information in the 2023 annual report remains unchanged except for the disclosed revisions[3]
阳光纸业(02002) - 2024 - 年度业绩